BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Meet the 5 Scientists Who Just Won Silicon Valley Billionaires’ Breakthrough Prize

  Five researchers were touted for their work in life sciences.

  December 5, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  What You Need to Know About CARMA Therapeutics

  CARMA Therapeutics is based on technology from the Center for Cellular Immunotherapies at the University of Pennsylvania, and was spun out of the laboratory of Saar Gill, assistant professor of Hematology Oncology in the Perelman School of Medicine there.

  December 5, 2017

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  1-Year Old Biotech Goldfinch Steals AstraZeneca R&D Exec for CEO Post

  Goldfinch Bio continues to expand its leadership team.

  December 5, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Job Trends

  1-Year old Biotech Startup LifeOmic to Create 225 Jobs at New HQ

  LifeOmic is planning to build new headquarters at the Indiana University Emerging Technology Center.

  December 5, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  Why Pfizer Could and Should Scoop Up Celgene in 2018

  Pfizer is no stranger to taking the big gambles-note the company’s attempts to buy Astra in 2014 and Allergan in 2016.

  December 5, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Biotech Bay

  Apple Works on Tackling Heart Disease With New Study

  A new application for its Apple Watch could save thousands of lives.

  December 5, 2017

   · 

  1 min read
• 

  Business

  San Diego’s Vital Therapies Names Ex-Jazz Pharma Exec as New Chief Leader

  Cox takes over for Vital Therapies CEO Terry Winters who will step down from the Vital Therapies Board and become a consultant to the company.

  December 5, 2017

   · 

  2 min read

   · 

  Alex Keown
• Drug Development

  Updated Results From Calithera Biosciences’ Phase I Study of CB-839 in Combination With Paclitaxel in Patients With Triple Negative Breast Cancer to be Presented at the 2017 San Antonio Breast Cancer Symposium

  Based on these data, Calithera has opened a Phase 2 trial exploring the treatment combination in both first line and late line metastatic TNBC patients.

  December 5, 2017

   · 

  5 min read
• Business

  InstruSafe by Summit Medical Partners with the Senhance Surgical Robotic System to Launch Two New Surgical Instrument Trays

  The two new trays — an instrument tray and an endoscopic adapter tray — have both been validated specifically for the Senhance instrumentation.

  December 5, 2017

   · 

  1 min read
• Drug Development

  Poseida Therapeutics Presents Preclinical Solid Tumor Data for P-PSMA-101 at the American Association for Cancer Research Prostate Cancer Meeting

  The study was selected for oral presentation today at the American Association for Cancer Research Prostate Cancer: Advances in Basic, Translational, and Clinical Research meeting in Orlando, Florida.

  December 5, 2017

   · 

  5 min read